Epidemiology of Clinically Relevant Bacterial Pathogens in a Burn Center in the Netherlands Between 2005 and 2011. Issue 3 (May 2015)

• Record Type: Journal Article
• Authors: Diederen, Bram M. W.; Wardle, Claire L. W.; Krijnen, Pieta; Tuinebreijer, Wim E.; Breederveld, Roelf S.
• Is Part Of: Journal of burn care & research. Volume 36:Issue 3(2015)
• Publication Date: 2015-05
• Subjects: Burns and scalds -- Treatment -- Periodicals; Burns and scalds -- Periodicals; Burns -- Periodicals; Burns -- rehabilitation -- Periodicals; Research -- Periodicals; Brûlés -- Réadaptation -- Périodiques; Brûlures -- Prévention -- Périodiques; Burns and scalds -- Patients; Periodicals; 617.11005
• DOI: 10.1097/BCR.0000000000000144
• Languages: English
• ISSNs: 1559-047X

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <p>The aim of this study was to analyze the epidemiology in the bacteriological profile and susceptibility of clinically relevant bacterial pathogens in a burn center in the Netherlands over a 7-year period. The swab results of 693 patients of the period 2005 to 2008 and 539 patients of the period 2009 to 2011 were studied for change of microorganisms and antibiotic resistance. Definitions according to the Working Party on Infection Prevention were used as a tool for assessing the scale of the resistance problem at a local level. Between the studied periods only small changes were found in the bacteriological profile. <italic>Staphylococcus aureus</italic> showed a slight increase of prevalence in inventory swabs during the second period. In both inventory and wound swabs, <italic>S. aureus</italic> is the most frequently isolated clinically relevant bacterial pathogen. Resistance for ciprofloxacin in <italic>Escherichia coli</italic> increased from 3% in 2005 to 2008 to 7% in 2009 to 2011 (<italic>P</italic> = .028). Resistance for cefotaxim in <italic>E. coli</italic> increased from 4% in 2005 to 2008 to 14% in 2009 to 2011, although this decrease was not statistically significant (<italic>P</italic> = .24). The prevalence of highly resistant microorganisms (HRMOs) remained low in both time periods, 4.9% in 2005 to 2008 and 7.4% in 2009 to 2011 (<italic>P</italic> = .063). The Netherlands is considered a low-prevalence country for antimicrobial resistance, and the occurrence of HRMOs in our center is relatively rare. A large percentage of HRMO isolates were extended spectrum β-lactamase producers, indicating the rapid increase in the production of this resistance mechanism in recent years. The transmission of HRMOs in our center is controlled effectively, using well-established transmission-based precautions.</p> </sec> </abstract>